Atomera Provides First Quarter 2025 Results
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, reported its Q1 2025 financial results. The company recorded a net loss of $5.2 million ($0.17 per share), compared to a loss of $4.8 million ($0.19 per share) in Q1 2024. Cash position stood at $24.1 million as of March 31, 2025, down from $26.8 million at the end of 2024.
Key developments include signing a strategic marketing agreement with a leading chip fabrication equipment vendor, expanding engagements with ST Microelectronics and RFSOI customers, and building first-ever MST-enabled GaN devices at Sandia. The company believes its new equipment vendor collaboration will drive license revenues while benefiting both parties.
Atomera (NASDAQ:ATOM), azienda specializzata in materiali e tecnologie per semiconduttori, ha comunicato i risultati finanziari del primo trimestre 2025. La società ha registrato una perdita netta di 5,2 milioni di dollari (0,17 dollari per azione), rispetto a una perdita di 4,8 milioni di dollari (0,19 dollari per azione) nel primo trimestre 2024. La posizione di cassa al 31 marzo 2025 era di 24,1 milioni di dollari, in calo rispetto ai 26,8 milioni di fine 2024.
Tra gli sviluppi principali si annoverano la firma di un accordo strategico di marketing con un importante fornitore di apparecchiature per la fabbricazione di chip, l'espansione delle collaborazioni con ST Microelectronics e clienti RFSOI, e la realizzazione dei primi dispositivi GaN abilitati MST presso Sandia. L'azienda ritiene che la nuova collaborazione con il fornitore di apparecchiature contribuirà ad aumentare i ricavi da licenze, apportando benefici a entrambe le parti.
Atomera (NASDAQ:ATOM), una empresa de materiales y licencias tecnológicas para semiconductores, reportó sus resultados financieros del primer trimestre de 2025. La compañía registró una pérdida neta de 5.2 millones de dólares (0.17 dólares por acción), en comparación con una pérdida de 4.8 millones de dólares (0.19 dólares por acción) en el primer trimestre de 2024. La posición de efectivo fue de 24.1 millones de dólares al 31 de marzo de 2025, disminuyendo desde 26.8 millones a finales de 2024.
Los desarrollos clave incluyen la firma de un acuerdo estratégico de marketing con un proveedor líder de equipamiento para fabricación de chips, la ampliación de compromisos con ST Microelectronics y clientes RFSOI, y la creación de los primeros dispositivos GaN habilitados con MST en Sandia. La empresa considera que la colaboración con el nuevo proveedor impulsará los ingresos por licencias, beneficiando a ambas partes.
Atomera (NASDAQ:ATOM)는 반도체 소재 및 기술 라이선스 회사로, 2025년 1분기 재무 실적을 발표했습니다. 회사는 2025년 1분기에 520만 달러 순손실(주당 0.17달러)을 기록했으며, 이는 2024년 1분기 480만 달러(주당 0.19달러) 손실과 비교됩니다. 2025년 3월 31일 기준 현금 보유액은 2410만 달러로, 2024년 말의 2680만 달러에서 감소했습니다.
주요 발전 사항으로는 선도적인 칩 제조 장비 공급업체와 전략적 마케팅 계약 체결, ST 마이크로일렉트로닉스 및 RFSOI 고객과의 협력 확대, Sandia에서 최초 MST 적용 GaN 장치 제작 등이 있습니다. 회사는 새로운 장비 공급업체와의 협력이 라이선스 수익을 증가시키고 양측 모두에 이익이 될 것으로 기대하고 있습니다.
Atomera (NASDAQ:ATOM), une société spécialisée dans les matériaux et licences technologiques pour semi-conducteurs, a publié ses résultats financiers du premier trimestre 2025. La société a enregistré une perte nette de 5,2 millions de dollars (0,17 dollar par action), contre une perte de 4,8 millions de dollars (0,19 dollar par action) au premier trimestre 2024. La trésorerie s’élevait à 24,1 millions de dollars au 31 mars 2025, en baisse par rapport à 26,8 millions à la fin de 2024.
Les principaux développements incluent la signature d’un accord stratégique de marketing avec un fournisseur majeur d’équipements de fabrication de puces, l’élargissement des collaborations avec ST Microelectronics et les clients RFSOI, ainsi que la fabrication des premiers dispositifs GaN équipés de MST chez Sandia. La société estime que cette nouvelle collaboration avec le fournisseur d’équipements stimulera les revenus de licences tout en profitant aux deux parties.
Atomera (NASDAQ:ATOM), ein Unternehmen für Halbleitermaterialien und Technologielizenzen, veröffentlichte seine Finanzergebnisse für das erste Quartal 2025. Das Unternehmen verzeichnete einen Nettoverlust von 5,2 Millionen US-Dollar (0,17 US-Dollar pro Aktie), verglichen mit einem Verlust von 4,8 Millionen US-Dollar (0,19 US-Dollar pro Aktie) im ersten Quartal 2024. Die Barreserve betrug zum 31. März 2025 24,1 Millionen US-Dollar, nach 26,8 Millionen US-Dollar Ende 2024.
Wichtige Entwicklungen umfassen den Abschluss einer strategischen Marketingvereinbarung mit einem führenden Anbieter von Chipfertigungsanlagen, die Erweiterung der Zusammenarbeit mit ST Microelectronics und RFSOI-Kunden sowie die Herstellung der ersten MST-fähigen GaN-Geräte bei Sandia. Das Unternehmen ist der Ansicht, dass die neue Kooperation mit dem Anlagenlieferanten die Lizenzumsätze steigern und beiden Parteien zugutekommen wird.
- Strategic marketing agreement secured with leading chip fabrication equipment vendor
- Expansion of engagements with ST Microelectronics and RFSOI customers to new applications
- Achievement of first MST-enabled GaN devices at Sandia
- Net loss increased to $5.2 million in Q1 2025 from $4.8 million in Q1 2024
- Cash position decreased to $24.1 million from $26.8 million in the previous quarter
- Adjusted EBITDA loss widened to $4.4 million from $4.0 million year-over-year
Insights
Atomera advances MST technology through equipment vendor partnership, expanded ST Micro applications, and first GaN devices with Sandia.
Atomera's Q1 announcement highlights strategic advancement for their MST semiconductor enhancement technology. The collaboration with an unnamed leading capital equipment company represents a potential inflection point. In semiconductor manufacturing, equipment vendor partnerships can significantly accelerate technology adoption by integrating new processes into established fabrication systems that chipmakers already trust and use.
The company reports expanded engagements with ST Microelectronics and their RFSOI customers to new applications. ST Micro's position as a major global semiconductor manufacturer makes their continued interest particularly noteworthy, as their product portfolio spans automotive, industrial, personal electronics, and communications infrastructure markets.
Perhaps most technically significant is Atomera's development of first MST-enabled GaN (Gallium Nitride) devices at Sandia National Laboratories, with electrical testing now underway. This expansion beyond silicon demonstrates MST's potential versatility. GaN technology is increasingly critical for high-power, high-frequency applications including power conversion, RF amplification, and emerging applications where silicon reaches physical limitations.
These developments collectively suggest Atomera is executing on multiple fronts to build technology credibility and create potential commercialization pathways, though as typical in semiconductor materials development, the progression from technical validation to commercial revenue often requires multiple years of qualification and integration work.
Atomera's widening losses and cash burn continue while pre-revenue development progresses; strategic partnerships may accelerate commercialization timeline.
Atomera's Q1 2025 financial results demonstrate the company's ongoing pre-revenue investment phase. The company reported a net loss of
The press release notably lacks mention of any revenue figures, suggesting limited or no revenue generation in the quarter as the company continues to focus on technology development and partnership building.
Atomera's cash position decreased by
The strategic marketing agreement with a capital equipment vendor and expanded customer engagements represent potential catalysts for future commercialization, though the press release provides no specific projections or timelines. For semiconductor materials companies like Atomera, the path from technology development to meaningful licensing revenue typically requires sustained investment through extended qualification cycles and integration into customer manufacturing processes.
With 30.7 million shares outstanding as of March 31, 2025, investors should monitor both technological progress and financial metrics in coming quarters for signs of commercial traction that could eventually translate to licensing revenue.
LOS GATOS, CA / ACCESS Newswire / May 6, 2025 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2025.
Recent Company Highlights
Signed strategic marketing agreement with leading chip fabrication equipment vendor
Expanded engagements at ST Microelectronics and RFSOI customers to new applications
Built first ever MST-enabled GaN devices at Sandia and began electrical testing
Management Commentary
"Our recently announced collaboration with a leading capital equipment company will strengthen Atomera's deal execution on many different levels. We believe the collaboration will drive our license revenues while growing our partner's capital equipment tool sales giving incentives for both of us to make it a success," said Scott Bibaud, President and CEO. "Our expansion to new application areas with ST and our fabless RF licensee are evidence of the growing opportunities available for MST as we deepen our relationships with our lead customers."
Financial Results
The Company incurred a net loss of (
The Company had
The total number of shares outstanding was 30.7 million as of March 31, 2025.
First Quarter 2025 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, May 6, 2025
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and knowhow and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on March 4, 2025. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow -
Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)
March 31, | December 31, | |||||||
2025 | 2024 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 24,123 | $ | 25,778 | ||||
Short-term investments | - | 995 | ||||||
Unbilled contracts receivable | - | 6 | ||||||
Interest receivable | 81 | 73 | ||||||
Prepaid expenses and other current assets | 335 | 240 | ||||||
Total current assets | 2,4539 | 27,092 | ||||||
Property and equipment, net | 52 | 59 | ||||||
Long-term prepaid maintenance and supplies | 91 | 91 | ||||||
Security deposit | 14 | 14 | ||||||
Operating lease right-of-use asset | 218 | 280 | ||||||
Financing lease right-of-use-asset | 1,338 | 1,588 | ||||||
Total assets | $ | 26,252 | $ | 29,124 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 761 | $ | 492 | ||||
Accrued expenses | 195 | 239 | ||||||
Accrued payroll related expenses | 402 | 1,328 | ||||||
Current operating lease liability | 184 | 260 | ||||||
Current financing lease liability | 1,314 | 1,253 | ||||||
Deferred Revenue | - | 4 | ||||||
Total current liabilities | 2,856 | 3,576 | ||||||
Long-term operating lease liability | - | 22 | ||||||
Long-term financing lease liability | 113 | 449 | ||||||
Total liabilities | 2,969 | 4,047 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholders' equity: | ||||||||
Preferred stock | - | - | ||||||
Common stock: | 31 | 31 | ||||||
Additional paid in capital | 249,981 | 246,565 | ||||||
Other comprehensive income (loss) | - | 1 | ||||||
Accumulated deficit | (226,729 | ) | (221,520 | ) | ||||
Total stockholders' equity | 23,283 | 25,077 | ||||||
Total liabilities and stockholders' equity | $ | 26,252 | $ | 29,124 | ||||
Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)
Three Months Ended | ||||||||||||
March 31, | December 31, | March 31, | ||||||||||
2025 | 2024 | 2024 | ||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | ||||||||||
Revenue | $ | 4 | $ | 23 | $ | 18 | ||||||
Cost of revenue | - | (13 | ) | (33 | ) | |||||||
Gross margin | 4 | 10 | (15 | ) | ||||||||
Operating expenses | ||||||||||||
Research and development | 3,255 | 2,823 | 2,858 | |||||||||
General and administrative | 2,088 | 1,811 | 1,811 | |||||||||
Selling and marketing | 124 | 248 | 350 | |||||||||
Total operating expenses | 5,467 | 4,882 | 5,019 | |||||||||
Loss from operations | (5,463 | ) | (4,872 | ) | (5,034 | ) | ||||||
Other income (expense) | ||||||||||||
Interest income | 270 | 213 | 205 | |||||||||
Accretion income | 6 | 26 | 46 | |||||||||
Interest Expense | (21 | ) | (25 | ) | (39 | ) | ||||||
Other income (expense), net | (1 | ) | 1 | - | ||||||||
Total other income (expense), net | 254 | 215 | 212 | |||||||||
Net loss | $ | (5,209 | ) | $ | (4,595 | ) | $ | (4,822 | ) | |||
Net loss per common share, basic and diluted | $ | (0.17 | ) | $ | (0.16 | ) | $ | (0.19 | ) | |||
Weighted average number of common shares outstanding, basic and diluted | 30,243 | 28,934 | 26,038 | |||||||||
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
Unaudited)
Three Months Ended | ||||||||||||
March 31, | December 31, | March 31, | ||||||||||
2025 | 2024 | 2024 | ||||||||||
Net loss (GAAP) | $ | (5,209 | ) | $ | (4,657 | ) | $ | (4,822 | ) | |||
Depreciation and amortization | 12 | 12 | 17 | |||||||||
Stock-based compensation | 1,009 | 949 | 1,024 | |||||||||
Interest income | (270 | ) | (213 | ) | (205 | ) | ||||||
Accretion income | (6 | ) | (26 | ) | (46 | ) | ||||||
Interest expense | 21 | 25 | 39 | |||||||||
Other (income) expense, net | 1 | (1 | ) | - | ||||||||
Net loss non-GAAP EBITDA | $ | (4,442 | ) | $ | (3,911 | ) | $ | (3,993 | ) | |||
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
SOURCE: Atomera, Inc
View the original press release on ACCESS Newswire
FAQ
What were Atomera's (ATOM) financial results for Q1 2025?
What major partnerships did Atomera (ATOM) announce in Q1 2025?
How much cash does Atomera (ATOM) have as of Q1 2025?
What technical milestone did Atomera (ATOM) achieve at Sandia in Q1 2025?
